-
1
-
-
35848968871
-
Prevalence of CKD in the US
-
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of CKD in the US. JAMA. 2007; 298: 2038-2047.
-
(2007)
JAMA
, vol.298
, pp. 2038-2047
-
-
Coresh, J.1
Selvin, E.2
Stevens, L.A.3
Manzi, J.4
Kusek, J.W.5
Eggers, P.6
Van Lente, F.7
Levey, A.S.8
-
2
-
-
4644221457
-
CKD and the risks of death, cardiovascular events, and hospitalization
-
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. CKD and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-1305.
-
(2004)
N Engl J Med
, vol.351
, pp. 1296-1305
-
-
Go, A.S.1
Chertow, G.M.2
Fan, D.3
McCulloch, C.E.4
Hsu, C.Y.5
-
3
-
-
34249080680
-
Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population
-
Zhang L, Zhao F, Yang Y, Qi L, Zhang B, Wang F, Wang S, Liu L, Wang H. Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population. Am J Kidney Dis. 2007; 49: 786-792.
-
(2007)
Am J Kidney Dis
, vol.49
, pp. 786-792
-
-
Zhang, L.1
Zhao, F.2
Yang, Y.3
Qi, L.4
Zhang, B.5
Wang, F.6
Wang, S.7
Liu, L.8
Wang, H.9
-
4
-
-
38349042470
-
CKD is associated with angiographic coronary artery disease
-
Chonchol M, Whittle J, Desbien A, Orner MB, Petersen LA, Kressin NR. CKD is associated with angiographic coronary artery disease. Am J Nephrol. 2008; 28: 354-360.
-
(2008)
Am J Nephrol
, vol.28
, pp. 354-360
-
-
Chonchol, M.1
Whittle, J.2
Desbien, A.3
Orner, M.B.4
Petersen, L.A.5
Kressin, N.R.6
-
5
-
-
39149122212
-
Hypertension and kidney disease: a deadly connection
-
Barri YM. Hypertension and kidney disease: a deadly connection. Curr Hypertens Rep. 2008; 10: 39-45.
-
(2008)
Curr Hypertens Rep
, vol.10
, pp. 39-45
-
-
Barri, Y.M.1
-
6
-
-
68149170224
-
Albuminuria and kid-ney function independently predict cardiovascular and renal outcomes in diabetes
-
Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J. Albuminuria and kid-ney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009; 20: 1813-1821.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 1813-1821
-
-
Ninomiya, T.1
Perkovic, V.2
de Galan, B.E.3
Zoungas, S.4
Pillai, A.5
Jardine, M.6
Patel, A.7
Cass, A.8
Neal, B.9
Poulter, N.10
Mogensen, C.E.11
Cooper, M.12
Marre, M.13
Williams, B.14
Hamet, P.15
Mancia, G.16
Woodward, M.17
Macmahon, S.18
Chalmers, J.19
-
7
-
-
3543139492
-
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
-
Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15: 2208-2218.
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 2208-2218
-
-
Block, G.A.1
Klassen, P.S.2
Lazarus, J.M.3
Ofsthun, N.4
Lowrie, E.G.5
Chertow, G.M.6
-
8
-
-
41049096380
-
Vitamin D deficiency and risk of CVD
-
Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of CVD. Circulation. 2008; 117: 503-511.
-
(2008)
Circulation
, vol.117
, pp. 503-511
-
-
Wang, T.J.1
Pencina, M.J.2
Booth, S.L.3
Jacques, P.F.4
Ingelsson, E.5
Lanier, K.6
Benjamin, E.J.7
D'Agostino, R.B.8
Wolf, M.9
Vasan, R.S.10
-
9
-
-
33845700085
-
Prevalence of abnormal serum vitamin D, PTH, Ca, and Pi in patients with CKD: results of the study to evaluate early kidney disease
-
Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL. Prevalence of abnormal serum vitamin D, PTH, Ca, and Pi in patients with CKD: results of the study to evaluate early kidney disease. Kidney Int. 2007; 71: 31-38.
-
(2007)
Kidney Int
, vol.71
, pp. 31-38
-
-
Levin, A.1
Bakris, G.L.2
Molitch, M.3
Smulders, M.4
Tian, J.5
Williams, L.A.6
Andress, D.L.7
-
10
-
-
84884828469
-
Photobiology of vitamin D
-
Feldman D, Pike JW, Glorieux FH (eds). 2nd Edition, NewYork: Elsevier Press
-
Holick M. Photobiology of vitamin D. In: Feldman D, Pike JW, Glorieux FH (eds). Vitamin D. 2nd Edition.NewYork: Elsevier Press; 2005. p. 37-46.
-
(2005)
Vitamin D
, pp. 37-46
-
-
Holick, M.1
-
11
-
-
54949087469
-
Vitamin D receptor ligand therapy in chronic kidney disease
-
Gonzalez E. Vitamin D receptor ligand therapy in chronic kidney disease. Clin Nephrol. 2008; 70: 271-283.
-
(2008)
Clin Nephrol
, vol.70
, pp. 271-283
-
-
Gonzalez, E.1
-
12
-
-
67651049740
-
Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the "U"
-
Cozzolino M, Brandenburg V. Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the "U". Clin Nephrol. 2009; 71: 593-601.
-
(2009)
Clin Nephrol
, vol.71
, pp. 593-601
-
-
Cozzolino, M.1
Brandenburg, V.2
-
13
-
-
34548202165
-
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
-
Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007; 7: 684-700.
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 684-700
-
-
Deeb, K.K.1
Trump, D.L.2
Johnson, C.S.3
-
14
-
-
0035092887
-
Extrarenal expression of 25-hydroxyvitamin d(3)-1 α-hydroxylase
-
Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M. Extrarenal expression of 25-hydroxyvitamin d(3)-1 ?-hydroxylase. J Clin Endocrinol Metab. 2001; 86: 888-894.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 888-894
-
-
Zehnder, D.1
Bland, R.2
Williams, M.C.3
McNinch, R.W.4
Howie, A.J.5
Stewart, P.M.6
Hewison, M.7
-
15
-
-
0023805793
-
Extra-renal production of calcitriol in chronic renal failure
-
Dusso A, Lopez-Hilker S, Rapp N, Slatopolsky E. Extra-renal production of calcitriol in chronic renal failure. Kidney Int. 1988; 34: 368-375.
-
(1988)
Kidney Int
, vol.34
, pp. 368-375
-
-
Dusso, A.1
Lopez-Hilker, S.2
Rapp, N.3
Slatopolsky, E.4
-
16
-
-
0020070118
-
Evidence for extrarenal production of 1α, 25-dihydroxyvitamin D in man
-
Lambert PW, Stern PH, Avioli RC, Brackett NC, Turner RT, Greene A, Fu IY, Bell NH. Evidence for extrarenal production of 1α,25-dihydroxyvitamin D in man. J Clin Invest. 1982; 69: 722-725.
-
(1982)
J Clin Invest
, vol.69
, pp. 722-725
-
-
Lambert, P.W.1
Stern, P.H.2
Avioli, R.C.3
Brackett, N.C.4
Turner, R.T.5
Greene, A.6
Fu, I.Y.7
Bell, N.H.8
-
17
-
-
0030759917
-
The vitaminDhormone and its nuclear receptor:molecular actions and disease states
-
Haussler MR, Haussler CA, Jurutka PW, Thompson PD,Hsieh JC,Remus LS, Selznick SH,Whitfield GK. The vitaminDhormone and its nuclear receptor:molecular actions and disease states. J Endocrinol. 1997; 154 (Suppl): 57-73.
-
(1997)
J Endocrinol
, vol.154
, Issue.SUPPL.
, pp. 57-73
-
-
Haussler, M.R.1
Haussler, C.A.2
Jurutka, P.W.3
Thompson, P.D.4
Hsieh, J.C.5
Remus, L.S.6
Selznick, S.H.7
Whitfield, G.K.8
-
19
-
-
34948882837
-
Nonclassical aspects of differential VDR activation: implications for survival in patients with CKD
-
Andress D. Nonclassical aspects of differential VDR activation: implications for survival in patients with CKD. Drugs. 2007; 67: 1999-2012.
-
(2007)
Drugs
, vol.67
, pp. 1999-2012
-
-
Andress, D.1
-
20
-
-
0026949697
-
1,25D3 inhibits cytokine production by human blood monocytes at the posttranscriptional level
-
Muller K, Haahr PM, Diamant M, Rieneck K, Kharazmi A, Bendtzen K. 1,25D3 inhibits cytokine production by human blood monocytes at the posttranscriptional level. Cytokine. 1992; 4: 506-512.
-
(1992)
Cytokine
, vol.4
, pp. 506-512
-
-
Muller, K.1
Haahr, P.M.2
Diamant, M.3
Rieneck, K.4
Kharazmi, A.5
Bendtzen, K.6
-
22
-
-
0036073755
-
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system
-
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110: 229-238.
-
(2002)
J Clin Invest
, vol.110
, pp. 229-238
-
-
Li, Y.C.1
Kong, J.2
Wei, M.3
Chen, Z.F.4
Liu, S.Q.5
Cao, L.P.6
-
23
-
-
0018942330
-
Target cells for 1,25D in the pancreas
-
Clark SA, Stumpf WE, Sar M, DeLuca HF, Tanaka Y. Target cells for 1,25D in the pancreas. Cell Tissue Res. 1980; 209: 515-520.
-
(1980)
Cell Tissue Res
, vol.209
, pp. 515-520
-
-
Clark, S.A.1
Stumpf, W.E.2
Sar, M.3
DeLuca, H.F.4
Tanaka, Y.5
-
24
-
-
0030700528
-
Association of calcitriol and blood pressure in normotensive men
-
Kristal-Boneh E,FroomP, HarariG,Ribak J. Association of calcitriol and blood pressure in normotensive men. Hypertension. 1997; 30: 1289-1294.
-
(1997)
Hypertension
, vol.30
, pp. 1289-1294
-
-
Kristal-Boneh, E.1
Froom, P.2
Harari, G.3
Ribak, J.4
-
25
-
-
20444441550
-
Relationship between fasting serum glucose, age, body mass index and serum25D in postmenopausal women
-
Need AG, O'Loughlin PD, Horowitz M, Nordin BE. Relationship between fasting serum glucose, age, body mass index and serum25D in postmenopausal women. Clin Endocrinol (Oxf). 2005; 62: 738-741.
-
(2005)
Clin Endocrinol (Oxf)
, vol.62
, pp. 738-741
-
-
Need, A.G.1
O'Loughlin, P.D.2
Horowitz, M.3
Nordin, B.E.4
-
26
-
-
6844257551
-
Hypovitaminosis D in medical inpatients
-
Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998; 338: 777-783.
-
(1998)
N Engl J Med
, vol.338
, pp. 777-783
-
-
Thomas, M.K.1
Lloyd-Jones, D.M.2
Thadhani, R.I.3
Shaw, A.C.4
Deraska, D.J.5
Kitch, B.T.6
Vamvakas, E.C.7
Dick, I.M.8
Prince, R.L.9
Finkelstein, J.S.10
-
27
-
-
41449084839
-
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease
-
Gutiérrez OMI, Andress DL, Levin A, Wolf M. Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease. Kidney Int. 2008; 73: 956-962.
-
(2008)
Kidney Int
, vol.73
, pp. 956-962
-
-
Gutiérrez, O.M.I.1
Andress, D.L.2
Levin, A.3
Wolf, M.4
-
28
-
-
20444428708
-
Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the US
-
LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the US. Am J Kidney Dis. 2005; 45: 1026-1033.
-
(2005)
Am J Kidney Dis
, vol.45
, pp. 1026-1033
-
-
LaClair, R.E.1
Hellman, R.N.2
Karp, S.L.3
Kraus, M.4
Ofner, S.5
Li, Q.6
Graves, K.L.7
Moe, S.M.8
-
29
-
-
10644280669
-
VitaminDinsufficiency and deficiency in CKD. A single center observational study
-
Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ. VitaminDinsufficiency and deficiency in CKD.A single center observational study. Am J Nephrol. 2004; 24: 503-510.
-
(2004)
Am J Nephrol
, vol.24
, pp. 503-510
-
-
Gonzalez, E.A.1
Sachdeva, A.2
Oliver, D.A.3
Martin, K.J.4
-
30
-
-
35948986295
-
Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and PTH in a cohort of pre-dialysis patients
-
Zehnder D, Landray MJ, Wheeler DC, Fraser W, Blackwell L, Nuttall S, Hughes SV, Townend J, Ferro C, Baigent C, Hewison M. Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and PTH in a cohort of pre-dialysis patients. Nephron Clin Pract. 2007; 107: 109-116.
-
(2007)
Nephron Clin Pract
, vol.107
, pp. 109-116
-
-
Zehnder, D.1
Landray, M.J.2
Wheeler, D.C.3
Fraser, W.4
Blackwell, L.5
Nuttall, S.6
Hughes, S.V.7
Townend, J.8
Ferro, C.9
Baigent, C.10
Hewison, M.11
-
31
-
-
0019986588
-
Metabolic acidosis suppresses 25-hydroxyvitamin in D3-1ahydroxylase in the rat kidney
-
Kawashima H, Kraut JA, Kurokawa K. Metabolic acidosis suppresses 25-hydroxyvitamin in D3-1ahydroxylase in the rat kidney. J Clin Invest. 1982; 70: 135-140.
-
(1982)
J Clin Invest
, vol.70
, pp. 135-140
-
-
Kawashima, H.1
Kraut, J.A.2
Kurokawa, K.3
-
33
-
-
0033582543
-
An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3
-
Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI, Willnow TE. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 1999; 96: 507-515.
-
(1999)
Cell
, vol.96
, pp. 507-515
-
-
Nykjaer, A.1
Dragun, D.2
Walther, D.3
Vorum, H.4
Jacobsen, C.5
Herz, J.6
Melsen, F.7
Christensen, E.I.8
Willnow, T.E.9
-
34
-
-
0030817895
-
Prevalence of vitaminDinsufficiency in an adult normal population
-
Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ. Prevalence of vitaminDinsufficiency in an adult normal population. Osteoporos Int. 1997; 7: 439-443.
-
(1997)
Osteoporos Int
, vol.7
, pp. 439-443
-
-
Chapuy, M.C.1
Preziosi, P.2
Maamer, M.3
Arnaud, S.4
Galan, P.5
Hercberg, S.6
Meunier, P.J.7
-
35
-
-
0023775923
-
SHPT and 1,25D deficiency in mild, moderate, and severe renal failure
-
Pitts TO, Piraino BH, Mitro R, Chen TC, SegreGV, Greenberg A, Puschett JB. SHPT and 1,25D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab. 1988; 67: 876-881.
-
(1988)
J Clin Endocrinol Metab
, vol.67
, pp. 876-881
-
-
Pitts, T.O.1
Piraino, B.H.2
Mitro, R.3
Chen, T.C.4
Segre, G.V.5
Greenberg, A.6
Puschett, J.B.7
-
36
-
-
27744545673
-
FGF-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in CKD
-
Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Juppner H, Wolf M. FGF-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in CKD. J Am Soc Nephrol. 2005; 16: 2205-2215.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 2205-2215
-
-
Gutierrez, O.1
Isakova, T.2
Rhee, E.3
Shah, A.4
Holmes, J.5
Collerone, G.6
Juppner, H.7
Wolf, M.8
-
37
-
-
0037462746
-
3 production
-
3 production. J Biol Chem. 2003; 278: 2206-2211.
-
(2003)
J Biol Chem
, vol.278
, pp. 2206-2211
-
-
Saito, H.1
Kusano, K.2
Kinosaki, M.3
Ito, H.4
Hirata, M.5
Segawa, H.6
Miyamoto, K.7
Fukushima, N.8
-
38
-
-
0021748474
-
Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients
-
Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest. 1984; 74: 2136-2143.
-
(1984)
J Clin Invest
, vol.74
, pp. 2136-2143
-
-
Slatopolsky, E.1
Weerts, C.2
Thielan, J.3
Horst, R.4
Harter, H.5
Martin, K.J.6
-
39
-
-
0028306074
-
Prospec-tive trial of pulse oral versus i.v. calcitriol treatment of SHPT in ESRD
-
Quarles LD, Yohay DA, Carroll BA, Spritzer CE, Minda SA, Bartholomay D, Lobaugh BA. Prospec-tive trial of pulse oral versus i.v. calcitriol treatment of SHPT in ESRD. Kidney Int. 1994; 45: 1710-1721.
-
(1994)
Kidney Int
, vol.45
, pp. 1710-1721
-
-
Quarles, L.D.1
Yohay, D.A.2
Carroll, B.A.3
Spritzer, C.E.4
Minda, S.A.5
Bartholomay, D.6
Lobaugh, B.A.7
-
41
-
-
46449131684
-
Independent association of low serum 25D and 1,25Dd levels with all-cause and CVmortality
-
DobnigH,Pilz S, Scharnagl H,RennerW, Seelhorst U,WellnitzB, Kinkeldei J,BoehmBO,WeihrauchG, Maerz W. Independent association of low serum 25D and 1,25Dd levels with all-cause and CVmortality. Arch Intern Med. 2008; 168: 1340-1349.
-
(2008)
Arch Intern Med
, vol.168
, pp. 1340-1349
-
-
Dobnig, H.1
Pilz, S.2
Scharnagl, H.3
Renner, W.4
Seelhorst, U.5
Wellnitz, B.6
Kinkeldei, J.7
Boehm, B.O.8
Weihrauch, G.9
Maerz, W.10
-
42
-
-
34548634762
-
Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials
-
Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007; 167: 1730-1737.
-
(2007)
Arch Intern Med
, vol.167
, pp. 1730-1737
-
-
Autier, P.1
Gandini, S.2
-
43
-
-
34948869354
-
Vitamin D levels and early mortality among incident HD patients
-
Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R. Vitamin D levels and early mortality among incident HD patients. Kidney Int. 2007; 72: 1004-1013.
-
(2007)
Kidney Int
, vol.72
, pp. 1004-1013
-
-
Wolf, M.1
Shah, A.2
Gutierrez, O.3
Ankers, E.4
Monroy, M.5
Tamez, H.6
Steele, D.7
Chang, Y.8
Camargo Jr., C.A.9
Tonelli, M.10
Thadhani, R.11
-
45
-
-
0036176161
-
-
K/DOQI. clinical practice guidelines for chronic kidney disease
-
K/DOQI clinical practice guidelines for chronic kidney disease.AmJ Kidney Dis. 2002; 39: 1-266.
-
(2002)
Am J Kidney Dis
, vol.39
, pp. 1-266
-
-
-
46
-
-
33847669753
-
Impact of ergocalciferol treatment of vitamin D deficiency on serum PTH concentrations in CKD
-
Zisman AL, Hristova M, Ho LT, Sprague SM. Impact of ergocalciferol treatment of vitamin D deficiency on serum PTH concentrations in CKD. Am J Nephrol. 2007; 27: 36-43.
-
(2007)
Am J Nephrol
, vol.27
, pp. 36-43
-
-
Zisman, A.L.1
Hristova, M.2
Ho, L.T.3
Sprague, S.M.4
-
47
-
-
34250771472
-
Changes in serum 25D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD
-
Al-Aly Z, Qazi RA, Gonzalez EA, Zeringue A, Martin KJ. Changes in serum 25D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. AmJ Kidney Dis. 2007; 50: 59-68.
-
(2007)
AmJ Kidney Dis
, vol.50
, pp. 59-68
-
-
Al-Aly, Z.1
Qazi, R.A.2
Gonzalez, E.A.3
Zeringue, A.4
Martin, K.J.5
-
49
-
-
8744276604
-
Vitamin D2 is much less effective than vitamin D3 in humans
-
Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004; 89: 5387-5391.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 5387-5391
-
-
Armas, L.A.1
Hollis, B.W.2
Heaney, R.P.3
-
50
-
-
32444447064
-
The impact of over-the-counter vitamin D supplements on vitamin D and parathyroid hormone levels in chronic kidney disease
-
Sekkarie M. The impact of over-the-counter vitamin D supplements on vitamin D and parathyroid hormone levels in chronic kidney disease. Clin Nephrol. 2006; 65: 91-96.
-
(2006)
Clin Nephrol
, vol.65
, pp. 91-96
-
-
Sekkarie, M.1
-
52
-
-
49649111989
-
Association of oral calcitriol with improved survival in nondialyzed CKD
-
Shoben AB, Rudser KD, de Boer IH, Young B, Kestenbaum B. Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol. 2008; 19: 1613-1619.
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 1613-1619
-
-
Shoben, A.B.1
Rudser, K.D.2
de Boer, I.H.3
Young, B.4
Kestenbaum, B.5
-
53
-
-
20844459261
-
Activated injectable vitamin D and HD survival: a historical cohort study
-
Teng M,Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, Thadhani R. Activated injectable vitamin D and HD survival: a historical cohort study. J Am Soc Nephrol. 2005; 16: 1115-1125.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 1115-1125
-
-
Teng, M.1
Wolf, M.2
Ofsthun, M.N.3
Lazarus, J.M.4
Hernan, M.A.5
Camargo Jr., C.A.6
Thadhani, R.7
-
54
-
-
33745210682
-
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
-
Kalantar-ZadehK,Kuwae N, Regidor DL,Kovesdy CP, Kilpatrick RD, Shinaberger CS,McAllister CJ, Budoff MJ, Salusky IB, Kopple JD. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006; 70: 771-780.
-
(2006)
Kidney Int
, vol.70
, pp. 771-780
-
-
Kalantar-Zadeh, K.1
Kuwae, N.2
Regidor, D.L.3
Kovesdy, C.P.4
Kilpatrick, R.D.5
Shinaberger, C.S.6
McAllister, C.J.7
Budoff, M.J.8
Salusky, I.B.9
Kopple, J.D.10
-
55
-
-
33644946514
-
ASN2005 Poster # TH-PO735
-
Young E. ASN2005 Poster # TH-PO735. JAmSoc Nephrol. 2005; 16: 278.
-
(2005)
JAmSoc Nephrol
, vol.16
, pp. 278
-
-
Young, E.1
-
56
-
-
60749091527
-
The survival advantage for HD patients taking vitamin Dis questioned: findings from the Dialysis Outcomes and Practice Patterns Study
-
Tentori F, Albert JM, Young EW, Blayney MJ, Robinson BM, Pisoni RL, Akiba T, Greenwood RN, Kimata N, Levin NW, Piera LM, Saran R, Wolfe RA, Port FK. The survival advantage for HD patients taking vitamin Dis questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2009; 24: 963-972.
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 963-972
-
-
Tentori, F.1
Albert, J.M.2
Young, E.W.3
Blayney, M.J.4
Robinson, B.M.5
Pisoni, R.L.6
Akiba, T.7
Greenwood, R.N.8
Kimata, N.9
Levin, N.W.10
Piera, L.M.11
Saran, R.12
Wolfe, R.A.13
Port, F.K.14
-
57
-
-
0042343804
-
Survival of patients undergoing HD with paricalcitol or calcitriol therapy
-
Teng M,Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R. Survival of patients undergoing HD with paricalcitol or calcitriol therapy. N Engl J Med. 2003; 349: 446-456.
-
(2003)
N Engl J Med
, vol.349
, pp. 446-456
-
-
Teng, M.1
Wolf, M.2
Lowrie, E.3
Ofsthun, N.4
Lazarus, J.M.5
Thadhani, R.6
-
58
-
-
33750576187
-
Mortality risk among HD patients receiving different vitamin D analogs
-
Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG. Mortality risk among HD patients receiving different vitamin D analogs. Kidney Int. 2006; 70: 1858-1865.
-
(2006)
Kidney Int
, vol.70
, pp. 1858-1865
-
-
Tentori, F.1
Hunt, W.C.2
Stidley, C.A.3
Rohrscheib, M.R.4
Bedrick, E.J.5
Meyer, K.B.6
Johnson, H.K.7
Zager, P.G.8
-
59
-
-
33846808897
-
Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients
-
Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract. 2007; 105: 132-138.
-
(2007)
Nephron Clin Pract
, vol.105
, pp. 132-138
-
-
Saab, G.1
Young, D.O.2
Gincherman, Y.3
Giles, K.4
Norwood, K.5
Coyne, D.W.6
-
60
-
-
0022959490
-
Influence of vitamin D or its metabolites on the rate of progression of chronic renal failure
-
Froehling PT, Kokot K, Vetter K, Kaschube I, Lindenau K. Influence of vitamin D or its metabolites on the rate of progression of chronic renal failure. Contrib Nephrol. 1986; 53: 64-70.
-
(1986)
Contrib Nephrol
, vol.53
, pp. 64-70
-
-
Froehling, P.T.1
Kokot, K.2
Vetter, K.3
Kaschube, I.4
Lindenau, K.5
-
61
-
-
32844466369
-
Antiproteinuric effect of oral paricalcitol in CKD
-
Agarwal R, Acharya M, Tian J, Hippensteel R, Melnick J, Qiu P, Williams L, Batlle D. Antiproteinuric effect of oral paricalcitol in CKD. Kidney Int. 2005; 68: 2823-2828.
-
(2005)
Kidney Int
, vol.68
, pp. 2823-2828
-
-
Agarwal, R.1
Acharya, M.2
Tian, J.3
Hippensteel, R.4
Melnick, J.5
Qiu, P.6
Williams, L.7
Batlle, D.8
-
62
-
-
49849104171
-
Paricalcitol reduces albuminuria and inflammation in CKD: a randomized double-blind pilot trial
-
Alborzi P, Patel NA, Peterson C, Bills JE, Bekele DM, Bunaye Z, Light RP, Agarwal R. Paricalcitol reduces albuminuria and inflammation in CKD: a randomized double-blind pilot trial. Hypertension. 2008; 52: 249-255.
-
(2008)
Hypertension
, vol.52
, pp. 249-255
-
-
Alborzi, P.1
Patel, N.A.2
Peterson, C.3
Bills, J.E.4
Bekele, D.M.5
Bunaye, Z.6
Light, R.P.7
Agarwal, R.8
-
64
-
-
1242351768
-
3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat
-
3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol. 2004; 286: 526-533.
-
(2004)
Am J Physiol Renal Physiol
, vol.286
, pp. 526-533
-
-
Kuhlmann, A.1
Haas, C.S.2
Gross, M.L.3
Reulbach, U.4
Holzinger, M.5
Schwarz, U.6
Ritz, E.7
Amann, K.8
-
65
-
-
0034950748
-
3 in experimental mesangial proliferative nephritis in rats
-
3 in experimental mesangial proliferative nephritis in rats. Kidney Int. 2001; 60: 87-95.
-
(2001)
Kidney Int
, vol.60
, pp. 87-95
-
-
Panichi, V.1
Migliori, M.2
Taccola, D.3
Filippi, C.4
De Nisco, L.5
Giovannini, L.6
Palla, R.7
Tetta, C.8
Camussi, G.9
-
66
-
-
31744439280
-
1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression
-
Li Y, Spataro BC, Yang J, Dai C, Liu Y. 1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression. Kidney Int. 2005; 68: 1500-1510.
-
(2005)
Kidney Int
, vol.68
, pp. 1500-1510
-
-
Li, Y.1
Spataro, B.C.2
Yang, J.3
Dai, C.4
Liu, Y.5
-
67
-
-
34447530298
-
3 targeting of NFκB suppresses high glucose-induced MCP-1 expression in mesangial cells
-
3 targeting of NFκB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int. 2007; 72: 193-201.
-
(2007)
Kidney Int
, vol.72
, pp. 193-201
-
-
Zhang, Z.1
Yuan, W.2
Sun, L.3
Szeto, F.L.4
Wong, K.E.5
Li, X.6
Kong, J.7
Li, Y.C.8
-
68
-
-
58149156441
-
VitaminD levels and patient outcome in CKD
-
Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C. VitaminD levels and patient outcome in CKD. Kidney Int. 2009; 75: 88-95.
-
(2009)
Kidney Int
, vol.75
, pp. 88-95
-
-
Ravani, P.1
Malberti, F.2
Tripepi, G.3
Pecchini, P.4
Cutrupi, S.5
Pizzini, P.6
Mallamaci, F.7
Zoccali, C.8
-
69
-
-
70349251198
-
Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial
-
Fishbane S, Chittineni H, Packman M, Dutka P, Ali N, Durie N. Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial. Am J Kidney Dis. 2009; 54: 647-652.
-
(2009)
Am J Kidney Dis
, vol.54
, pp. 647-652
-
-
Fishbane, S.1
Chittineni, H.2
Packman, M.3
Dutka, P.4
Ali, N.5
Durie, N.6
|